vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and RadNet, Inc. (RDNT). Click either name above to swap in a different company.

APTARGROUP, INC. is the larger business by last-quarter revenue ($982.9M vs $547.7M, roughly 1.8× RadNet, Inc.). APTARGROUP, INC. runs the higher net margin — 7.4% vs -0.1%, a 7.5% gap on every dollar of revenue. On growth, RadNet, Inc. posted the faster year-over-year revenue change (14.8% vs 10.8%). Over the past eight quarters, RadNet, Inc.'s revenue compounded faster (12.6% CAGR vs 3.9%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

RadNet is an American radiology firm. The company operates outpatient diagnostic imaging services. Headquartered in Los Angeles, California, RadNet is the largest operator of freestanding, fixed-site diagnostic imaging centers in the United States, based on the number of locations and annual imaging revenue. As of 2025, the company owns and/or operates over 400 imaging centers across Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas.

ATR vs RDNT — Head-to-Head

Bigger by revenue
ATR
ATR
1.8× larger
ATR
$982.9M
$547.7M
RDNT
Growing faster (revenue YoY)
RDNT
RDNT
+4.0% gap
RDNT
14.8%
10.8%
ATR
Higher net margin
ATR
ATR
7.5% more per $
ATR
7.4%
-0.1%
RDNT
Faster 2-yr revenue CAGR
RDNT
RDNT
Annualised
RDNT
12.6%
3.9%
ATR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ATR
ATR
RDNT
RDNT
Revenue
$982.9M
$547.7M
Net Profit
$72.8M
$-597.0K
Gross Margin
Operating Margin
10.9%
5.1%
Net Margin
7.4%
-0.1%
Revenue YoY
10.8%
14.8%
Net Profit YoY
-7.5%
-111.2%
EPS (diluted)
$1.12
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
RDNT
RDNT
Q1 26
$982.9M
Q4 25
$962.7M
$547.7M
Q3 25
$961.1M
$522.9M
Q2 25
$966.0M
$498.2M
Q1 25
$887.3M
$471.4M
Q4 24
$848.1M
$477.1M
Q3 24
$909.3M
$461.1M
Q2 24
$910.1M
$459.7M
Net Profit
ATR
ATR
RDNT
RDNT
Q1 26
$72.8M
Q4 25
$74.3M
$-597.0K
Q3 25
$127.9M
$5.4M
Q2 25
$111.7M
$14.5M
Q1 25
$78.8M
$-37.9M
Q4 24
$100.9M
$5.3M
Q3 24
$100.0M
$3.2M
Q2 24
$90.5M
$-3.0M
Operating Margin
ATR
ATR
RDNT
RDNT
Q1 26
10.9%
Q4 25
11.0%
5.1%
Q3 25
14.2%
5.2%
Q2 25
14.9%
6.2%
Q1 25
12.8%
-5.1%
Q4 24
14.2%
5.1%
Q3 24
15.2%
7.4%
Q2 24
13.8%
7.6%
Net Margin
ATR
ATR
RDNT
RDNT
Q1 26
7.4%
Q4 25
7.7%
-0.1%
Q3 25
13.3%
1.0%
Q2 25
11.6%
2.9%
Q1 25
8.9%
-8.0%
Q4 24
11.9%
1.1%
Q3 24
11.0%
0.7%
Q2 24
9.9%
-0.6%
EPS (diluted)
ATR
ATR
RDNT
RDNT
Q1 26
$1.12
Q4 25
$1.13
$0.00
Q3 25
$1.92
$0.07
Q2 25
$1.67
$0.19
Q1 25
$1.17
$-0.51
Q4 24
$1.48
$0.08
Q3 24
$1.48
$0.04
Q2 24
$1.34
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
RDNT
RDNT
Cash + ST InvestmentsLiquidity on hand
$229.5M
$767.2M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$2.6B
$1.1B
Total Assets
$5.1B
$3.8B
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
RDNT
RDNT
Q1 26
$229.5M
Q4 25
$409.5M
$767.2M
Q3 25
$264.8M
$804.7M
Q2 25
$169.8M
$833.2M
Q1 25
$136.8M
$717.3M
Q4 24
$226.2M
$740.0M
Q3 24
$327.9M
$748.9M
Q2 24
$223.9M
$741.7M
Total Debt
ATR
ATR
RDNT
RDNT
Q1 26
Q4 25
$1.1B
$1.1B
Q3 25
$546.0M
$1.1B
Q2 25
$535.1M
$1.1B
Q1 25
$561.2M
$1.0B
Q4 24
$688.1M
$1.0B
Q3 24
$822.7M
$1.0B
Q2 24
$681.5M
$1.0B
Stockholders' Equity
ATR
ATR
RDNT
RDNT
Q1 26
$2.6B
Q4 25
$2.7B
$1.1B
Q3 25
$2.8B
$1.1B
Q2 25
$2.7B
$932.3M
Q1 25
$2.5B
$898.1M
Q4 24
$2.5B
$902.3M
Q3 24
$2.5B
$895.3M
Q2 24
$2.4B
$881.0M
Total Assets
ATR
ATR
RDNT
RDNT
Q1 26
$5.1B
Q4 25
$5.3B
$3.8B
Q3 25
$5.1B
$3.7B
Q2 25
$4.9B
$3.5B
Q1 25
$4.5B
$3.3B
Q4 24
$4.4B
$3.3B
Q3 24
$4.6B
$3.3B
Q2 24
$4.5B
$3.2B
Debt / Equity
ATR
ATR
RDNT
RDNT
Q1 26
Q4 25
0.43×
1.00×
Q3 25
0.20×
1.04×
Q2 25
0.20×
1.18×
Q1 25
0.22×
1.12×
Q4 24
0.28×
1.13×
Q3 24
0.32×
1.14×
Q2 24
0.28×
1.17×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
RDNT
RDNT
Operating Cash FlowLast quarter
$84.2M
Free Cash FlowOCF − Capex
$53.3M
FCF MarginFCF / Revenue
5.4%
Capex IntensityCapex / Revenue
6.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$327.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
RDNT
RDNT
Q1 26
Q4 25
$183.7M
$84.2M
Q3 25
$177.6M
$52.8M
Q2 25
$126.0M
$120.3M
Q1 25
$82.7M
$41.5M
Q4 24
$178.2M
$42.5M
Q3 24
$229.3M
$57.4M
Q2 24
$143.6M
$116.0M
Free Cash Flow
ATR
ATR
RDNT
RDNT
Q1 26
$53.3M
Q4 25
$96.9M
Q3 25
$114.3M
Q2 25
$62.5M
Q1 25
$25.9M
Q4 24
$112.2M
Q3 24
$162.7M
Q2 24
$75.4M
FCF Margin
ATR
ATR
RDNT
RDNT
Q1 26
5.4%
Q4 25
10.1%
Q3 25
11.9%
Q2 25
6.5%
Q1 25
2.9%
Q4 24
13.2%
Q3 24
17.9%
Q2 24
8.3%
Capex Intensity
ATR
ATR
RDNT
RDNT
Q1 26
6.7%
Q4 25
9.0%
Q3 25
6.6%
Q2 25
6.6%
Q1 25
6.4%
Q4 24
7.8%
Q3 24
7.3%
Q2 24
7.5%
Cash Conversion
ATR
ATR
RDNT
RDNT
Q1 26
Q4 25
2.47×
Q3 25
1.39×
9.75×
Q2 25
1.13×
8.33×
Q1 25
1.05×
Q4 24
1.77×
7.96×
Q3 24
2.29×
17.89×
Q2 24
1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Segment breakdown not available.

RDNT
RDNT

Commercial Insurance1$301.0M55%
Medicare1$129.2M24%
Capitation Arrangements$31.9M6%
Health Care Other$20.4M4%
Digital Health$16.4M3%
Other$15.2M3%
Medicaid1$14.0M3%
Workers Compensation Personal Injury1$12.3M2%
Health Care Management Service$7.5M1%

Related Comparisons